Joseph C. Galante, Director at CUMBERLAND PHARMACEUTICALS INC (CPIX), bought 2,982 shares at $3.34 ($9K) on 2021-08-02, disclosed to the SEC on 2021-09-10.
Scheduled purchase ($9k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.34 | 142 | $474 | 5.3% |
| 2 | $3.17 | 142 | $450 | 5.1% |
| 3 | $3.18 | 142 | $452 | 5.1% |
| 4 | $3.11 | 142 | $442 | 5.0% |
| 5 | $3.01 | 142 | $427 | 4.8% |
| 6 | $2.93 | 142 |
| $416 |
| 4.7% |
| 7 | $2.96 | 142 | $420 | 4.7% |
| 8 | $2.98 | 142 | $423 | 4.8% |
| 9 | $2.92 | 142 | $415 | 4.7% |
| 10 | $2.92 | 142 | $415 | 4.7% |
| 11 | $3.05 | 142 | $433 | 4.9% |
| 12 | $2.97 | 142 | $422 | 4.7% |
| 13 | $3.02 | 142 | $429 | 4.8% |
| 14 | $2.96 | 142 | $420 | 4.7% |
| 15 | $2.87 | 142 | $408 | 4.6% |
| 16 | $2.89 | 142 | $410 | 4.6% |
| 17 | $2.79 | 142 | $396 | 4.5% |
| 18 | $2.82 | 142 | $400 | 4.5% |
| 19 | $2.84 | 142 | $403 | 4.5% |
| 20 | $2.88 | 142 | $409 | 4.6% |
| 21 | $2.93 | 142 | $416 | 4.7% |
| Total | $2.98 avg | 2,982 | $9K | 100% |
| Filing → |
| CPIX | BUY | 2022-12-23 | $3K | — | Filing → |
| CPIX | BUY | 2022-11-18 | $4K | — | Filing → |
| CPIX | BUY | 2022-09-30 | $5K | — | Filing → |